Is PHARMAC’s decision-making fair? Findings from an evaluation of decision-making in the New Zealand health system

Illustrated person with an oversized red question mark over their head

25 May 2022

Tumilty et al.

The recent publication of the interim report of the PHARMAC Review Panel raises important questions of the role and processes of PHARMAC in securing equitable access to pharmaceuticals for all New Zealanders.

Read more

Other stories

Academic Literature
Principles for embedding learning and adaptation into New Zealand health system functioning: the example of the Viable System Model

Principles for embedding learning and adaptation into New Zealand health system functioning: the example of the Viable System Model

The New Zealand health system is large, complex and subject to ongoing change. To be viable over the long term, as for any system, our health system must take a consistent, continuous approach to learning. Read...

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.